Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives.
about
Vaxjo: a web-based vaccine adjuvant database and its application for analysis of vaccine adjuvants and their uses in vaccine developmentAdjuvants: Classification, Modus Operandi, and LicensingAdvances in aluminum hydroxide-based adjuvant research and its mechanismThe quest for better understanding of HLA-disease association: scenes from a road less travelled byHuman peptidoglycan recognition protein-L is an N-acetylmuramoyl-L-alanine amidaseAdjuvants and antibody production: dispelling the myths associated with Freund's complete and other adjuvantsStimulation of macrophage protease secretion via liposomal delivery of muramyl dipeptide derivatives to intracellular sitesAdjuvant activity of 6-amino-6-deoxy-muramyldipeptides and their acylamino derivatives on the induction of delayed hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigsDetection of muramic acid in a carbohydrate fraction of human spleenMuramyl dipeptide induces NOD2-dependent Ly6C(high) monocyte recruitment to the lungs and protects against influenza virus infectionIsolation and characterization of the aspartokinase and aspartate semialdehyde dehydrogenase operon from mycobacteriaMolecular characterization of in vivo adjuvant activity in ferrets vaccinated against influenza virusMetabolic labelling of the carbohydrate core in bacterial peptidoglycan and its applicationsFailure of synthetic muramyl dipeptide to increase antibacterial resistance.Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs.Macrophage stimulation in vitro by an inactive muramyl dipeptide derivative after conjugation to a multi-poly(DL-alanyl)-poly(L-lysine) carrier.Arthritis-inducing ability of a synthetic adjuvant, N-acetylmuramyl peptides, and bacterial disaccharide peptides related to different oil vehicles and their compositionComparison of muramyl dipeptide, trehalose dimycolate, and dimethyl dioctadecyl ammonium bromide as adjuvants in Brucella abortus 45/20 vaccinesEffects of treatment with muramyl dipeptide and certain of its analogs on resistance to Listeria monocytogenes in mice.Improving vaccine performance with adjuvants.Enhancement of certain biological activities of muramyl dipeptide derivatives after conjugation to a multi-poly(DL-alanine)--poly(L-lysine) carrier.Mycobacterium.Role of Staphylococcus aureus cell wall antigens in the stimulation of delayed hypersensitivity after staphylococcal infection.Granuloma formation by synthetic bacterial cell wall fragment: muramyl dipeptide.Adjuvant activity of 6-O-mycoloyl derivatives of N-acetylmuramyl-L-seryl-D-isoglutamine and related compounds in mice and guinea pigs.Stimulation of the reticuloendothelial system of mice by muramyl dipeptide.Adjuvant activities in production of reaginic antibody by bacterial cell wall peptidoglycan or synthetic N-acetylmuramyl dipeptides in mice.Enhancement of host resistance against Trypanosoma cruzi infection by the immunoregulatory agent muramyl dipeptideMitogenic effects of bacterial cell walls, their fragments, and related synthetic compounds on thymocytes and splenocytes of guinea pigs.Synergistic effect of polyriboinosinic acid:polyribocytidylic acid and either bacterial peptidoglycans or synthetic N-acetylmuramyl peptides on production of adjuvant-induced arthritis in rats.A structure-activity relationship for induction of meningeal inflammation by muramyl peptidesUnleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants.Activity in saline of phthalylated or succinylated derivatives of mycobacterial water-soluble adjuvant.Defined synthetic vaccines.Tumor necrosis factor amplifies measles virus-mediated Ia induction on astrocytes.Vaccine adjuvants: current state and future trends.Adjuvant activity of mycobacterial fractions: adjuvant activity of synthetic N-acetylmuramyl-dipeptide and the related compounds.Adjuvanticity (immunity-inducing property) of cord factor in mice and rats.Adjuvant activity of synthetic N-acetylmuramyl peptides in rats.Adjuvant activity of synthetic 6-O-"mycoloyl"-N-acetylmuramyl-L-alanyl-D-isoglutamine and related compounds
P2860
Q21284959-9BDF1AE0-970C-41BF-ABF5-D872F0C270A5Q26747586-89460B7C-3A37-40CA-964C-C3E24AE7E33FQ27007659-1C794C34-F525-4970-BDB6-0C8D15178252Q27013863-FB9574CA-4162-4D32-9D88-71DD5F26632BQ28115452-27C22CBC-340E-493C-B8A4-96C1974008D1Q28256294-33497DB9-F903-423F-8F7E-147BBB74C67EQ28366436-01A84010-A1B2-45A3-8E30-DE74E8B07A01Q28368029-E204A812-71CD-4E63-B952-52C0DDC7F1B6Q28368097-EA3170AF-DD08-46D9-9EF6-2CD3DA768DA8Q28483612-71274A77-59D7-4631-9356-D552AD479EA9Q28487345-8DA120CA-8CCC-42B9-B3FE-45DB5167F417Q30390170-EDA43EE3-F574-460B-99A1-ACD374186BA7Q33622000-FD7B31D7-0501-428B-AE42-228E704AFCCFQ33898795-FDF3F7C1-BC32-453B-9585-5C30E09ECC12Q33900509-EFAC5196-F9EF-423A-9BCF-23DF5F5501B7Q33901649-DCC463C1-3B91-45E5-979C-EBC7A785BC54Q33904886-7C4A049F-BC31-4FE1-B936-6FBF66ECD12DQ33910267-E11A2DF9-7882-4801-99E3-AA9E65FA9DC2Q33910568-B80784E7-EE0C-4C31-A833-43B12E62B93AQ33956247-87238DEB-81B3-440E-BD3E-7AB477233295Q33989809-38482F2B-5CCD-4F7C-9F9E-E68CE221CFEAQ34072948-A28E08D5-3E39-4934-AFAC-503B53AE336CQ34075777-04A415F4-07AF-4040-94BB-6FD2BE285134Q34077109-85F6945E-FAA1-4633-93EC-F2515FA40B38Q34081553-5DDBA440-5B75-488B-8054-821F88E9E094Q34082722-C64876D7-E849-4FE3-AB61-CCB515DB0991Q34082822-97868B5B-32EC-4F5C-80CF-5505F5D7D438Q34088685-31F408A5-D9E5-4BD9-8356-0CA56E1C67DCQ34090068-94AA557F-4AB4-46E1-96C7-72A68032952DQ34098306-CC081668-63F1-4046-B5D5-EC0030FA43DAQ34112614-18482AD6-5C2A-4CF5-A1CE-4C65BAF563DAQ34120040-364E801C-AB20-48AD-9691-922DFA3BE5AFQ34136895-5100EC3A-A51B-4510-8809-4FE2A555900EQ34280941-B68C48AD-A6AD-470A-BD77-5D1DD49AABAFQ34354649-953A6BB9-C2E2-42F8-BA4C-889FBE9F25B7Q34358206-308878C2-BEEE-4C75-8EF6-41C6DD9943C3Q34398908-4471E38F-181D-4C12-BED5-E24014ED625DQ34408416-075F1577-7FAD-4F13-B897-B0F1EB33CFC1Q34423831-576E9CC0-9A3E-4C2A-998F-14DA0D8DB2C8Q34446761-5BAAECED-CCF0-44C8-A426-C0F4DB18917B
P2860
Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives.
description
1974 nî lūn-bûn
@nan
1974年の論文
@ja
1974年学术文章
@wuu
1974年学术文章
@zh-cn
1974年学术文章
@zh-hans
1974年学术文章
@zh-my
1974年学术文章
@zh-sg
1974年學術文章
@yue
1974年學術文章
@zh
1974年學術文章
@zh-hant
name
Minimal structural requirement ...... ial peptidoglycan derivatives.
@en
Minimal structural requirement ...... ial peptidoglycan derivatives.
@nl
type
label
Minimal structural requirement ...... ial peptidoglycan derivatives.
@en
Minimal structural requirement ...... ial peptidoglycan derivatives.
@nl
prefLabel
Minimal structural requirement ...... ial peptidoglycan derivatives.
@en
Minimal structural requirement ...... ial peptidoglycan derivatives.
@nl
P2093
P1476
Minimal structural requirement ...... ial peptidoglycan derivatives.
@en
P2093
P304
P356
10.1016/0006-291X(74)90458-6
P407
P577
1974-08-01T00:00:00Z